Gram-Negative Bacteria Protein and CD 14 in Immune Responses Critical Role of Lipopolysaccharide-Binding

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• PRETREATMENT WITH RECOMBINANT MURINE TUMOR NECROSIS FACTOR cdCACHECTIN AND MURINE INTERLEUKIN 1 a PROTECTS MICE FROM LETHAL BACTERIAL INFECTION

  2003cited by this paper
• Cytokine signaling--regulation of the immune response in normal and critically ill states.

  2000cited by this paper
• Blockade of CD14 Increases Shigella-Mediated Invasion and Tissue Destruction1

  2000cited by this paper
• Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity.

  2000cited by this paper
• Reduced antilisterial activity of TNF‐deficient bone marrow‐derived macrophages is due to impaired superoxide production

  1999cited by this paper
• Inhibition by a CD14 monoclonal antibody of lipopolysaccharide binding to murine macrophages

  1999cited by this paper
• Tumor necrosis factor alpha receptor I is important for survival from Streptococcus pneumoniae infections.

  1999cited by this paper
• LBP or the Presentation of LPS / LBP by Blocking Either the Binding of LPS to ( LBP ) Protect Mice from Lethal Endotoxemia Lipopolysaccharide ( LPS )-Binding Protein Monoclonal Antibodies to Murine

  1999cited by this paper
• Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin.

  1998cited by this paper
• Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice.

  1997cited by this paper
• Phagocytosis of Gram‐negative bacteria by a unique CD14‐dependent mechanism

  1997cited by this paper
• Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection

  1997cited by this paper
• Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice.

  1996cited by this paper
• Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia

  1996cited by this paper
• Antibodies against CD14 protect primates from endotoxin-induced shock.

  1996cited by this paper
• Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism.

  1996cited by this paper
• Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice

  1996cited by this paper
• Results of passive and active immunization directed against ferric aerobactin in experimental enterobacterial infections in mice and chickens.

  1995cited by this paper
• Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa

  1995cited by this paper
• Reactivity of murine and human recombinant LPS-binding protein (LBP) within LPS and gram negative bacteria.

  1995cited by this paper
• Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice.

  1994cited by this paper
• Anti-tumor necrosis factor antibodies inhibit the influx of granulocytes and monocytes into an inflammatory exudate and enhance the growth of Listeria monocytogenes in various organs.

  1994cited by this paper
• Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes

  1993cited by this paper
• Choice of bacteria in animal models of sepsis

  1993cited by this paper
• Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock.

  1993cited by this paper
• Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.

  1992cited by this paper
• Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes.

  1992cited by this paper
• Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis.

  1991cited by this paper
• Structure and function of lipopolysaccharide binding protein.

  1990cited by this paper
• CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

  1990cited by this paper
• Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis.

  1990cited by this paper
• Protective effect of recombinant tumor necrosis factor-α in murine salmonellosis.

  1990cited by this paper
• Evidence that tumor necrosis factor has an important role in antibacterial resistance.

  1989cited by this paper
• Effects of tumor necrosis factor on PMN chemotaxis, chemiluminescence, and elastase activity.

  1989cited by this paper
• Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor.

  1987cited by this paper

• Usefulness of presepsin as diagnostic and prognostic marker of sepsis in daily clinical practice.

  2019cites this paper
• Anti‐human CD14 monoclonal antibody improves survival following sepsis induced by endotoxin, but not following polymicrobial infection

  2017cites this paper
• Organization and consequences of functional responses in microglia upon activation of the TLR4 complex

  2014cites this paper
• Lipopolysaccharide binding protein in the early diagnosis of intraamniotic infection of pregnant women with premature rupture of the membranes

  2009cites this paper
• HIV-1 infection of mononuclear phagocytic cells : the case for bacterial innate immune defi ciency in AIDS

  2006cites this paper
• Invited review: Detoxifying endotoxin: time, place and person

  2005cites this paper
• LPS-binding protein-deficient mice have an impaired defense against Gram-negative but not Gram-positive pneumonia.

  2004cites this paper
• The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds

  2003cites this paper
• Inflammatory Bowel Disease: Is the Intestine a Trojan Horse?

  2002cites this paper